Thought Leader Liaison (South Central)
Travere Therapeutics
Summary
The Thought Leader Liaison (TLL) is a field-based role that will be responsible for developing and managing strategic partnerships on behalf of Travere with national and regional US key opinion leaders (KOLs) within the rare nephrology space. This position will report to the Director, Thought Leader Liaisons and will help support the successful growth of FILSPARI® (sparsentan) for IgAN and FSGS. With supervision, this individual will collaborate cross-functionally on field activities as a strategic business partner with Marketing, Insights and Analytics, Sales management, Patient Advocacy, Compliance, Sales Training, Market Access, and Medical Affairs. The preferred candidate will bring a deep understanding of nephrology, ideally with a focus on rare kidney diseases. They will have a demonstrated ability to engage with academic thought leaders and cultivate a community of brand advocates, driving impact through personalized interactions, focused small group meetings, and influential advisory boards.
Job description
Responsibilities
- Leverage insights to implement regional cross-functional account strategy and KOL engagement plan in partnership with the brand team and field partners (MSLs and sales representatives)
- Collaborate and coordinate closely with marketing to identify partnering opportunities with KOLs and assist with KOL recruitment for specific marketing initiatives
- Actively collect, analyze, and synthesize information on KOL sentiments, competitor activities, and broader market trends from diverse sources (1:1 meetings, advisory boards, congresses). Provide the brand team with regular updates, including strategic recommendations
- Ensure compliant, fair-balanced, and effective message delivery within all promotional educational channels (i.e., speaker programs, product theaters, exhibitor spotlights, etc.)
- Enlist appropriate KOLs to successfully support commercial activities, in partnership with the FILSPARI® brand team
- Work with field partners to identify and vet qualified promotional speakers that align with overall needs of the brand
- Assist with the contracting, training, and on-going educational efforts with contracted promotional speakers
Education/Experience Requirements
- Bachelor’s Degree in Business or Life Sciences discipline. Advanced degree preferred but not required. Equivalent combination of education and applicable job experience may be considered.
- Minimum of 8 years of related Marketing experience in specialty or rare disease marketing
Additional Skills/Experience/Requirements
- The ideal candidate will embody Travere’s core values: Courage, Community Spirit, Patient Focus and Teamwork
- Strong scientific acumen and understanding of specialty clinical medicine
- Proven, consistent history of high performance and leadership
- Demonstrated ability to build and sustain exceptional business relationships internal commercial and cross-functional partners
- Demonstrated ability to build productive KOL relationships and effectively execute engagement plans
- Strong professional experience in a similar role within the pharmaceutical industry, preferably small molecule pharmaceuticals
- Excellent collaboration skills with strong attention to detail and the ability to multi-task and manage complexity
- Strong interpersonal and organizational skills and excellent verbal and written communication skills are required
- Successful record of creating and managing complex project plans, timelines, budgets, and critical paths
- Ability to adapt to modification and changes to project plans, demonstrating flexibility to implement new strategies and tactics to accommodate these changes
- The position is field-based and the candidate must live in their region
- Ability to travel 50-60% domestically. In the field a minimum of 3 days a week and some weekend work as required
Requirements
- Bachelor’s Degree in Business or Life Sciences discipline
- Minimum of 8 years of related Marketing experience in specialty or rare disease marketing
- Strong scientific acumen and understanding of specialty clinical medicine
- Proven, consistent history of high performance and leadership
- Demonstrated ability to build and sustain exceptional business relationships internal commercial and cross-functional partners
- Demonstrated ability to build productive KOL relationships and effectively execute engagement plans
- Strong professional experience in a similar role within the pharmaceutical industry, preferably small molecule pharmaceuticals
- Excellent collaboration skills with strong attention to detail and the ability to multi-task and manage complexity
- Strong interpersonal and organizational skills and excellent verbal and written communication skills are required
- Successful record of creating and managing complex project plans, timelines, budgets, and critical paths
- Ability to adapt to modification and changes to project plans, demonstrating flexibility to implement new strategies and tactics to accommodate these changes
- The position is field-based and the candidate must live in their region
- Ability to travel 50-60% domestically. In the field a minimum of 3 days a week and some weekend work as required
Benefits
- Health insurance
- Financial offerings
- Work-life balance programs
- Well-being offerings
- Wellness programs
- Employee support programs
- Life insurance
- Disability insurance
- Retirement plans
- Employer match
- Paid time off
- Short-term incentive
- Long-term incentive compensation
Company overview
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, dedicated to identifying, developing, and delivering life-changing therapies for people living with rare kidney and metabolic diseases. Founded in 2011 as Retrophin and rebranded as Travere Therapeutics in 2020, the company has established itself as a leader in rare disease therapeutics with a focused pipeline targeting conditions with significant unmet medical needs. Their flagship product, FILSPARI® (sparsentan), received full FDA approval in September 2024 to slow kidney function decline in adults with primary IgA nephropathy (IgAN) who are at risk for disease progression. The company also has a Phase 3 clinical program for pegtibatinase (TVT-058) targeting classical homocystinuria (HCU), a rare genetic metabolic disorder. Travere maintains a commercial portfolio including Thiola EC® and Thiola® for cystinuria, demonstrating their commitment to serving rare disease communities through comprehensive therapeutic solutions. With a global presence and strategic partnerships, Travere Therapeutics continues to advance innovative treatments while supporting patient access and education initiatives for rare disease populations.